Dec 13, 2017 - Names on the move ahead of the open.
Sep 15, 2017 - A splashy acquisition that puts this company on the cutting edge of cancer treatment isn't the only reason to buy shares. Gilead Sciences' margins are among the best in biotech, and its valuation arguably makes it a bargain.
Sep 04, 2017 - 99% of biotech stocks don't pay a dividend -- but these two have a market-topping yield.
Sep 13, 2017 - AbbVie's great dividend should get even better.
Feb 27, 2017 - Pharma Industry Outlook - February/March 2017
Apr 27, 2017 - Is it time for Amgen to spend some of its cash stockpile? The big biotech's Q1 results say "yes."
Sep 17, 2018 - A new migraine drug is a big win amid the turnaround of generics business.
Jul 23, 2017 - While the market just keeps going up, there's still some value to be found.
Jul 25, 2016 - Amgen and Gilead Sciences are both reporting earnings this week. Which company is the better bet right now?
Aug 26, 2017 - Pfizer and Amgen are encountering problems getting traction for their biosimilars. Is the system rigged against them?